Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TarMart Lifescience, an extension of GeneMedi, is a biotechnology company and research tool provider based in Shanghai, China. The company specializes in providing a comprehensive suite of biological reagents, including viral vectors (AAV, Lentivirus, Adenovirus), recombinant proteins, antibodies, and siRNA oligos to support drug discovery and diagnostic development. TarMart leverages GeneMedi's proprietary platforms, such as the Taurus™ antibody discovery platform and the LIBRA™ AI-driven protein evolution platform, to deliver high-quality tools for therapeutic target exploration. With manufacturing capabilities up to 1000L, the company serves global pharmaceutical and academic clients, focusing on gene and cell therapy (GCT) and biologics innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TarMart Lifescience.